Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

The medical term for this is pruritus. With PV, people might also experience skin itching, burning, stinging, or tickling. The symptoms can be mild or so severe that they interfere with daily life.

Clinical efficacy was assessed using clinical outcome measures, such as the Eczema Area and Severity Index (EASI), and patient-reported outcome measures, such as the numerical rating scale (NRS) for ...

The primary endpoint of the study is to evaluate the clinical efficacy of the two dose levels compared to placebo using the Peak Pruritus Numerical Rating Scale (PP-NRS) at Week 16, a well ...

The significant burden imposed by AD on patients and the health care system includes increases in hospitalizations, health care costs, loss of work productivity, and disability. 9-14 This impact ...